Comparison

Moracin T European Partner

Item no. TMO-TN4582-1mg
Manufacturer TargetMol
CASRN 1146113-27-0
Amount 1 mg
Quantity options 1 mL 1 mg 5 mg
Category
Type Molecules
Specific against other
Smiles OC=1C=C(O)C=C(C1)C=2OC3=CC(O)=C(OC)C(=C3C2)CC=C(C)C
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 1146113-27-0
Shipping Condition Cool pack
Available
Manufacturer - Targets
COX|||c-Myc
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
340.37
Description
Moracin treatment can inhibit the double 12-O-tetradecanoylphorbol 13-acetate (TPA) treatment-induced morphological changes reflecting inflammatory response, including leucocyte infiltration, hyperplasia and cell proliferation; moracin treatment furthermore can significantly suppress the elevation in 4-HNE level and elevate expression of c-fos, c-myc and cycloxygenase-2 (COX-2) in normal epidermis induced by double application of TPA; the moracin may be protective influence in tumor promotion, utilization of Moracin may open a new avenue in the treatment of tumerigenesis.
Pathways
Immunology/Inflammation|||Cell Cycle/Checkpoint|||Neuroscience

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?